Viral, Parasitic, Bacterial, and Fungal Infections
Antimicrobial, Host Defense, and Therapeutic Strategies
- 1 Edición - 15 de octubre de 2022
- Última edición
- Editores: Debasis Bagchi, Amitava Das, Bernard William Downs
- Idioma: Inglés
Viral, Parasitic, Bacterial, and Fungal Infections: Antimicrobial, Host Defense, and Therapeutic Strategies highlight diverse types of infections, including viral, bacterial… Leer más
Descripción
Descripción
Viral, Parasitic, Bacterial, and Fungal Infections: Antimicrobial, Host Defense, and Therapeutic Strategies highlight diverse types of infections, including viral, bacterial, parasitic, fungal, and the therapeutic efficacy of antibiotics, antivirals, antifungals and other medications, nutraceuticals, and phytotherapeutics. This book addresses the molecular, pathophysiological, and cellular pathways involved in the process of infection. It also examines the host defense mechanisms modulated by innate and adaptive immunity. The book starts off with an introduction, which includes etiology, pathophysiology, and diagnosis of infections. It then goes on to cover a wide spectrum of salient features involved in viral, bacterial, parasitic, and fungal infections and effective therapeutic strategies. In addition, there is a complete section of eight chapters elaborating the detailed aspects of COVID-19 infections, Mucormycosis, Omicron, and strategic vaccines and therapeutics. The book further goes on to discuss novel antibiotics, vaccines, bromhexine, boron compounds, phytotherapeutics, and aspects on boosting immune competence. Contributed by experts in the fields of viral, parasitic, bacterial, and fungal infections, the book comprehensively details the various types of infections such as herpes and COVID-19, their molecular mechanisms, and treatment strategies for those engaged in the research of infectious diseases.
Puntos claves
Puntos claves
- Details the pathophysiology of various classes of infections
- Examines mechanisms of pathogenesis, immunity, and therapeutics in bacterial, viral, and eukaryotic infectious diseases
- Discusses various aspects on herpes, COVID-19 infections, Mucormycosis, Omicron, vaccines, and therapeutics
- Covers the salient features on zoonosis, prion disease, and diabetic foot infections
- Provides therapeutic strategies of using new antibiotics, vaccines, bromhexine, boron compounds, structurally diverse phytotherapeutics, immune enhancers, and other modalities for treating infections
De interès para
De interès para
Índice
Índice
INTRODUCTION
1. Infections: Definitions, classification and etiology
2. Pathophysiology of Infections
3. Diagnosis of Infection
4. Non-Coding RNA: An Overview
BACTERIAL INFECTIONS AND THERAPEUTICS
5. Bacterial infection and their treatment
6. Novel strategies of combating bacterial infection
7. Role of miRNA in bacterial infection
8. AMPs and host defense against bacterial infection
9. Role of nutrients in combating infection
VIRAL INFECTIONS AND THERAPEUTICS
10. Viral Infection and its management
11. Novel strategies to eliminate viral infections
12. The menace of HIV infection
13. Unmasking an Idiopathic Nemesis: The Herpes Virus
14. Zika Virus infections
15. Ebola Virus: Pathogenesis and Treatment
16. Pathophysiology, Detection and Treatment of CoronaVirus
17. Pandemic of Covid-19
FUNGAL INFECTIONS AND THERAPEUTICS
18. Fungal infections: An unrecognized threat
19. Combinatorial strategies for combating fungal infections
20. Sepsis: Prolific Hypoxia-induced Incubation of Anaerobic Organisms
21. Biofilm infection
PARASITIC INFECTIONS AND THERAPEUTICS
22. Parasitic infection
23. Leishmaniasis and its treatment
24. Malaria: Diagnosis, treatment and control
25. Neglected Parasitic Infections
26. Prion diseases
OTHER INFECTIONS AND THERAPEUTICS
27. Development of point-of-care for bacterial infections
28. Surgical Infections
Detalles del producto
Detalles del producto
- Edición: 1
- Última edición
- Publicado: 16 de octubre de 2022
- Idioma: Inglés
Sobre los editores
Sobre los editores
DB
Debasis Bagchi
Debasis Bagchi earned his Ph.D. in Medicinal Chemistry in 1982 and is a Professor in the Department of Pharmacological and Pharmaceutical Sciences at the University of Houston College of Pharmacy. He also serves as Chief Scientific Officer at Cepham Research Center and holds adjunct faculty appointments. Previously, he was Senior Vice President of Research & Development at InterHealth Nutraceuticals (1998–2011) and later Director of Innovation and Clinical Affairs at Iovate Health Sciences (2011–2013).
Dr. Bagchi received the Master of the American College of Nutrition Award in 2010 and has held leadership roles including Past President of the American College of Nutrition and Past Chairman of the International Society of Nutraceuticals and Functional Foods. He contributes as an NIH peer reviewer and advisor to international health organizations.
A prolific scholar, he has authored over 320 peer-reviewed papers, 30 books, and holds 18 patents. He also serves on editorial boards of numerous scientific journals.
AD
Amitava Das
BD